The Approval Process in Action

Life Sciences Tools & DiagnosticsMedical DevicesRegenerative MedicineBiotechnology / Pharmaceuticals

Source: The Life Sciences Report and Visual Capitalist (5/1/13)

What catalysts in the drug development process move biotech company stocks? The savvy investor must know what steps in the U.S. Food and Drug Administration's approval process can propel a stock up or down. From drug discovery to the much-anticipated PDUFA date, The Life Sciences Report and the Visual Capitalist have collaborated on an infographic that describes both the process and related catalysts.

US Biotech Co. Targets Muscuar Dystrophy with First-In-Class Drug
Source: Streetwise Reports (06/01/2026)

Capricor Therapeutics Inc.'s (CAPR:NASDAQ) Deramiocel targets FDA approval by August 2026, with analysts issuing Buy ratings and price targets as high as US$60.

New Alzheimer's Imaging Push Expands as Financing Terms Get Investor-Friendly
Source: Streetwise Reports (05/29/2026)

Grey Matters Health Inc. (GREY:CSE; AGW0:FRA; AGNPF:OTCQB) amended warrant terms tied to its CA$1 million private placement as it advances plans for a U.S. brain-specific neuroimaging clinic focused on Alzheimer's diagnostics.

Biopharma Company Reveals High-Impact SCI Recovery Gains
Source: Streetwise Reports (05/28/2026)

NervGen Pharma Corp. (NGEN:TSX.V; NGENF:OTCQX) reports 100% responder rates for NVG-291 in spinal cord injury trials, strengthening hopes for major recovery breakthroughs.

200 Brain PET Scans, 162 Alzheimer's Drugs: A Diagnostic Push Takes Shape
Source: Streetwise Reports (05/22/2026)

Grey Matters Health Inc. (GREY:CSE; AGW0:FRA; AGNPF:OTCQB) signed an LOI tied to a minimum of 200 brain PET scans for an Alzheimer's clinical trial while expanding its NovaScan neuroimaging strategy.

Cleantech Co. Wins PFAS Deal, Engineering Pact, Ships Clyra
Source: Richard Ryan (05/21/2026)

BioLargo (BLGO:OTCQX) shipped Clyra's first stocking order, signed Aquatech PFAS MOU, and won a US$1.2M engineering contract for a minerals processing facility, according to an Oak Ridge Financial research note